


The Fund aims to achieve above average capital growth.
| Name | % Net Assets |
|---|---|
| Roche Holding AG | 5.6% |
| BG GROUP | 4.6% |
| EFG Eurobank Ergasias S.A. | 4.3% |
| ASML Holding N.V. | 4.2% |
| Lanxess AG | 3.8% |
| Key | % Net Assets |
|---|---|
| 5.6% | |
| 4.6% | |
| 4.3% | |
| 4.2% | |
| 81.3% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 604.82p |
| Currency | GBP |
| Change | -0.42p |
| % | -0.07% |
| YTD change | 60.52p |
| YTD % | 11.12% |
| Fund Inception | 12/07/2004 |
|---|---|
| Fund Manager | Phil Cliff |
| TER | 1.10 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £50000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.09 |
You are here: research